HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Libra, M Articles by Malaponte, G Search for Related Content PubMed PubMed Citation Articles by Libra, M Articles by Malaponte, G Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Diabetes Peripheral Vascular Diseases

Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease

¹ Department of Biomedical Sciences, University of Catania, Via Androne, 83-95124, Catania, Italy
² Department of Internal Medicine, Angiology Unit, University of Catania
³ Epidemiology Unit, Centro di Riferimento Oncologico, 33081 Aviano, Italy

Correspondence to:
Dr G Malaponte
Department of Biomedical Sciences, University of Catania, Via Androne, 83-95124 Catania, Italy; g.malaponte{at}unict.it Aims: To determine whether the G(–174)C interleukin 6 (IL-6) polymorphism influences the development of peripheral arterial disease (PAD) in individuals with type 2 diabetes. This was investigated by comparing the distribution of G(–174)C genotypes between patients with type 2 diabetes and PAD (PAD⁺) and those with type 2 diabetes but without PAD (PAD^–). Plasma concentrations of IL-6, fibrinogen, C reactive protein (CRP), and vascular endothelial growth factor (VEGF) were also compared in PAD⁺ and PAD^– patients.

Methods: Blood samples were collected from 146 PAD⁺ and 144 PAD^– patients. SfaNI was used to determine the G(–174)C genotype. Plasma concentrations of IL-6, fibrinogen, CRP, and VEGF were measured by an enzyme linked immunosorbent assay.

Results: The GG genotype was more common in PAD⁺ patients than in PAD^– patients. PAD⁺ patients also had increased mean plasma concentrations of IL-6, fibrinogen, CRP, and VEGF compared with PAD^– patients. Mean plasma concentrations of IL-6, fibrinogen, and CRP in both PAD⁺ and PAD^– patients were higher in those with the GG genotype than in those with the GC or CC genotypes. In contrast, mean plasma concentrations of VEGF in PAD⁺ and PAD^– patients were not significantly different between those with different G(–174)C genotypes.

Conclusions: These results support a model in which the GG genotype promotes PAD development among individuals with type 2 diabetes by inducing increased release of IL-6. Higher concentrations of IL-6 among those with the GG genotype is associated with increased plasma concentrations of fibrinogen and CRP.

Abbreviations: CRP, C reactive protein; IL-6, interleukin 6; PAD, peripheral arterial disease; PCR, polymerase chain reaction; VEGF, vascular endothelial growth factor

Keywords: inflammation; interleukin-6; peripheral arterial disease; type 2 diabetes mellitus

This article has been cited by other articles:

				H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 299 - 309. [Abstract] [PDF]